Furthermore, silencing SHMT1 with low SLC19A1 expression inhibits tumor growth by impairing pyrimidine biosynthesis in vitro and in vivo, whereas silencing SHMT1 with SLC19A1 overexpression cannot alleviate tumor growth. The gene discussed is SLC19A1; the disease is neoplasm.